P53, A TARGET ANTIGEN FOR IMMUNOTHERAPY IN OVARIAN CANCER - FROM PRECLINIC TO CLINIC. Issue 1 (1st March 2003) - Nijman, H. W.; vd Burg, S. H.; Zwaveling, S.; Melief, K. M.J.; vd Zee, A. G.J.; Offringa, R.